- 182
- 62 839
Cancer Genomics Consortium
United States
Приєднався 13 сер 2018
The Cancer Genomics Consortium (CGC - cancergenomics.org) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is for all cancer patients to be accurately diagnosed for their underlying genomic alterations to help them receive the most appropriate therapy. CGC aims to be the authoritative organization for guidance on the best practice of clinical cancer genomic testing. This UA-cam channel makes selected presentations from Annual CGC Meetings available for public viewing. Please visit cancergenomics.org to become a member and gain full access to our complete library of presentations.
Using ClinVar to Share Germline & Somatic Variant Classifications from Clinical Genomic Testing
CGC Webinar: Using ClinVar to Share Germline and Somatic Variant Classificationsfrom Clinical Genomic Testing for Cancer
December 17, 2024
Clinical genetics testing laboratories have benefited from sharing variant classifications of germline variants for monogenic disorders with ClinVar since its introduction in 2013. In January 2024, ClinVar was updated to accept classifications of somatic variants for cancer, including assertions of oncogenicity and clinical impact. In this webinar, Melissa J. Landrum PhD and Sharon E. Plon MD, PhD will describe how genetic testing laboratories have benefited from sharing germline variants through ClinVar, and how cancer testing laboratories can take advantage of sharing classifications of somatic variants.
December 17, 2024
Clinical genetics testing laboratories have benefited from sharing variant classifications of germline variants for monogenic disorders with ClinVar since its introduction in 2013. In January 2024, ClinVar was updated to accept classifications of somatic variants for cancer, including assertions of oncogenicity and clinical impact. In this webinar, Melissa J. Landrum PhD and Sharon E. Plon MD, PhD will describe how genetic testing laboratories have benefited from sharing germline variants through ClinVar, and how cancer testing laboratories can take advantage of sharing classifications of somatic variants.
Переглядів: 50
Відео
Exhibitor Showcase: Thermo Fisher
Переглядів 182 місяці тому
Exhibitor Showcase: Thermo Fisher Scientific Chromosomal microarray analysis to the rescue: Diagnosis of challenging intracranial tumors Madina Sukhanova - CGC 2024 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting bes...
Exhibitor Showcase: Natera
Переглядів 792 місяці тому
Exhibitor Showcase: Natera Personalized MRD assessment to inform treatment decisions in patients with solid tumor cancers Tanner Hagelstrom - CGC 2024 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in...
Exhibitor Showcase: Bionano
Переглядів 452 місяці тому
Exhibitor Showcase: Bionano Improving sensitivity and workflow efficiency in myeloid malignancy research with optical genome mapping: A multi-institutional study Phillip Michaels - CGC 2024 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in ed...
Exhibitor Showcase: Guardant
Переглядів 872 місяці тому
Exhibitor Showcase: Guardant Liquid Biopsy in Cancer Care: Current Applications and Future Signatures Jill Tsai - CGC 2024 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. O...
Exhibitor Showcase: Novartis
Переглядів 252 місяці тому
Exhibitor Showcase: Novartis Early Breast Cancer: Biomarker Testing and Assessing Risk of Recurrence Roger Bishop - CGC 2024 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics....
Exhibitor Showcase: Illumina's Oncology Testing Portfolio
Переглядів 252 місяці тому
Exhibitor Showcase: Illumina's Oncology Testing Portfolio Shayan Langha - CGC 2024 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is for all cancer patients to ...
Exhibitor Showcase: QIAGEN
Переглядів 92 місяці тому
Exhibitor Showcase: QIAGEN Expert perspectives on the challenges and opportunities of implementing comprehensive genomic profiling Ravindra Kolhe - CGC 2024 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practi...
Integrative cytogenetic & molecular studies unmasks Chromosomal Mimicry in hematologic malignancies
Переглядів 826 місяців тому
Integrative cytogenetic and molecular studies unmasks 'Chromosomal Mimicry' in hematologic malignancies Samuel Brody - CGC 2023 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomi...
Implementing the ClinGen/CGC/VICC Oncogenicity Guidelines in a pediatric variant classification
Переглядів 1346 місяців тому
Implementing the ClinGen/CGC/VICC Oncogenicity Guidelines in a pediatric variant classification workflow Wesley Goar - CGC 2023 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomi...
Utilizing rapid molecular testing to reduce disparities in pediatric cancer in Sub-Saharan Africa
Переглядів 5816 місяців тому
Utilizing rapid molecular testing to reduce disparities in pediatric cancer in Sub-Saharan Africa Julie Gastier-Foster - CGC 2023 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer geno...
Frequency and etiology of cytogenetically cryptic oncogenic fusions in pediatric AML
Переглядів 5567 місяців тому
Frequency and etiology of cytogenetically cryptic oncogenic fusions in pediatric AML Gordana Raca - CGC 2023 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer genomics. Our vision is f...
Prognostic significance of copy number gain of MYC detected by FISH analysis
Переглядів 1,3 тис.7 місяців тому
Prognostic significance of copy number gain of MYC detected by FISH analysis in large B-cell lymphoma Madina Sukhanova - CGC 2023 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical cancer geno...
Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients
Переглядів 4398 місяців тому
Cell-free DNA genomic and epigenomic analysis to predict survival in mCRPC patients treated with AR-directed therapy Pradeep Chauhan - CGC 2023 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinic...
Comparative analysis of RNA expression identifies druggable targets in pediatric solid tumors
Переглядів 7568 місяців тому
Comparative analysis of RNA expression identifies druggable targets in difficult-to-treat pediatric solid tumors Yvonne Vasquez - CGC 2023 Annual Meeting The Cancer Genomics Consortium (CGC - cancergenomics.org/) represents a dedicated group of clinical cytogeneticists, molecular geneticists, and molecular pathologists, who are interested in education and promoting best practices in clinical ca...
Investigation of pathogenic and truncated variants of RUNX1 and DDX41 in All of Us
Переглядів 8388 місяців тому
Investigation of pathogenic and truncated variants of RUNX1 and DDX41 in All of Us
ClinGen Cancer Variant Interpretation (CVI) Committee
Переглядів 1,4 тис.8 місяців тому
ClinGen Cancer Variant Interpretation (CVI) Committee
Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumors
Переглядів 6 тис.8 місяців тому
Personalized sequencing assays for cerebrospinal fluid liquid biopsies in children with brain tumors
A new age in cancer genomics from single cell transcriptomics to liquid biopsy
Переглядів 1 тис.9 місяців тому
A new age in cancer genomics from single cell transcriptomics to liquid biopsy
A female-specific chimeric RNA with differential expression in COVID patients
Переглядів 7 тис.9 місяців тому
A female-specific chimeric RNA with differential expression in COVID patients
Fusion curation interface: An educational tool to explore a unified framework
Переглядів 2109 місяців тому
Fusion curation interface: An educational tool to explore a unified framework
Whole transcriptome sequencing as a diagnostic tool for AML
Переглядів 6649 місяців тому
Whole transcriptome sequencing as a diagnostic tool for AML
Chromosomal microarray analysis work-up for hypocellular MDS patients with inconclusive cytogenetics
Переглядів 26010 місяців тому
Chromosomal microarray analysis work-up for hypocellular MDS patients with inconclusive cytogenetics
Mapping variants from multiplex assays of variant effect (MAVEs) to human reference sequences
Переглядів 37410 місяців тому
Mapping variants from multiplex assays of variant effect (MAVEs) to human reference sequences
Overcoming challenges in semantic alignment of therapeutics knowledge using Therapy
Переглядів 37910 місяців тому
Overcoming challenges in semantic alignment of therapeutics knowledge using Therapy
Keynote Presentation -Somatic mutations and their contribution to bone marrow failure & inflammation
Переглядів 43211 місяців тому
Keynote Presentation -Somatic mutations and their contribution to bone marrow failure & inflammation
Spotlight Symposium: GOAL Consortium
Переглядів 41011 місяців тому
Spotlight Symposium: GOAL Consortium
Invited Speaker Presentation-TP53 alterations in myelodysplastic neoplasms & acute myeloid leukemia
Переглядів 1,4 тис.11 місяців тому
Invited Speaker Presentation-TP53 alterations in myelodysplastic neoplasms & acute myeloid leukemia
Keynote Presentation - Incorporating genomic information in the treatment of MDS
Переглядів 91011 місяців тому
Keynote Presentation - Incorporating genomic information in the treatment of MDS
WHO/IARC Overview and CGC Collaboration
Переглядів 25911 місяців тому
WHO/IARC Overview and CGC Collaboration
Interestingly, mutations in the exon 1-3 in IL12RB2 could lead to upregulation of stemness and a lack of differentation due to defective JMJD3-dependent demathylase of H3K27me3/2 as well as defective JMJD3-dependent Brg1 in the SWI/SNF complex while cooperating with T-bet-mediated H3K4me3. The time point for the upregulation of IL12RB2 mRNA and protein expression, which takes place upon IL-2-induced STAT5 activation before the clonal expansion of T-cells and differentiation of TH1, could be an important interface for epigenetic mechanisms regulating chromatin accessability during T-cell differentiation and T-cell mediated maturation/priming of DCs,- possibly regulating both T-cell lineage commitment, APC maturation and the final exit from innate to adaptive immunity. Furthermore, IL12RB2 is expressed in both neuronal and epithelial (including thymic) cells, which could be interesting to study due to potential crosstalk mechanisms between T-cells and cancer cells with a stem-like gene signature. In T-cell/DC crosstalk, the early expression of IL12RB2 mRNA seems connected to activation of p38 mapk phosphorylation (H3S10ser), which is positioned in the important CD40L-CD40 axis and leads to finalisation of the innate type 1 IFN response and correct transition into the adaptive,- even controling the confirmational switch between early TGF-beta-dependent IL-12p70 production and p38 mapk-dependent IL-12p70 via mediating the full transcription of the IL-12p35 subunit. The dynamics of T-bet-defecient cells as well as IL12RB2-defecient cells (if defecient in the first exons,- exon 1-3 and intragenic regions), show a prolonged IFN-alpha production and a defective negative regulation of the type 1 IFN gene signature which suggest a delayed transition to adaptive immunity, as seen in TLR9 stimulation...
MDS/AML with mutated TP53 is in the ICC
SOMATIC MUTATION THEORY IS FRAUD CANCER IS A METABOLIC DISEASE OTTO WARBURG
Thank you Cancer Genomics Consortium. Greetings from Molecular Biology, Env. and Cancer Research Group, universidad del Cauca, Colombia.
80⁰❤😂🎉😢😮😅
😔 'Promo sm'
Thank you CGC.
youtube.com/@hironyarabha1959?sub_confirmation=1
Thank you so much. Greetings from Molecular Biology, Env. and Cancer Research Group (Bimac) at Universidad del Cauca, Colombia.
One quick question that have you used hybrid capture probes for this work?
Bionano Genomics? Hello?
Hello plz i really need your help what if i have to elaborate on the qualities that a biochemical change should posses for it to be used as an ideal biomarker
Can I get your email ID please, my wife's age 35yrs has been diagnosed with AML, with normal female karyotype and NGS showing an ETV6 mutation with amino acid change p.(N405Afs) *19
I couldn't agree more. Great Video 💎! You are late to the party > P-R-O-M-O-S-M!
nvyp6 vum.fyi
🧬 ARKG is noT buying b/c BNGO wont discuss trade secret info w/ Simon. secretive like Apple’s iCar project that will take over all tsla manufacturing by 2030. start n 2024 and decisively be over by 2027.
I enjoyed the video so much. I've been trying to research for UA-cam vid like yours that really educates the ideas in this video. The part at 1:30 is my fav. Your explanation really is similar to the videos of Dr. Ethan. Ethan's tips are really informative and he helped me a lot on wellness. He is the most informative Dr in the UK and he teaches conditions! I recommend you see his page out and give the medical student a subscribe! 👉 #DoctorEthanWellness
Thanks to everyone taking their time to read this testimony on how my son was saved from Autism. He was diagnosed four years ago, and he's just 6, I have tried several treatments and medications, nothing was working out, this got me frustrated and depressed. I kept praying and finally God answered my prayers when someone from youtube introduced me to this doctor from his home country and gave me his contact details. I called and explained my son's condition after which I made an order for his herbal remedy, he asked for my address and the next day I got a tracking number for a parcel sent to me through DHL and after four days I received my order. It was a liquid herbal medicine and a letter containing the instructions on how to use the herbs, I called him again to confirm and the next morning I started giving my son the herbs as instructed and after one week I noticed great improvement on my son as he was able to speak nomal and I continued until the herbs got finished and everything lasted for just one month and now my son is totally free from Autism, he can now talk clearly, behave normal and has no more seizures.i'm so happy to share tothe wold thegeat wok of DR okosun , i now believe herbal medicine is the cure to all sickness and disease.If you've been searching for a genuine solution for Autism your answer is Dr Okosun, connect with him on whatsApp fo a honest and sincere conversation before getting the medicine , contact him today on Whatsapp at +2348157012553......,
Nice presentation.
Glad you liked it